Cross-species comparison and validation for drug discovery and biomarker research using QIAGEN Ingenuity Pathway Analysis (IPA)

September 27, 2023
Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research is a crucial method to collect data to examine potential toxicity for a candidate drug, determine the efficacious doses that may be suitable for humans, identify potential biomarkers for a disease of interest or a therapeutic response and understand the mechanisms of disease or treatment. While animal models and humans have similar anatomy and physiology, the subtle differences among organisms in the animal kingdom need to be considered and data collected must be interpreted using a meaningful method.

Using QIAGEN IPA, you can perform comparative analyses across various animal models, even combining different time points, treatments, tissues and cell types with data generated from a wide variety of ‘omics technologies (RNA-seq, scRNA-seq, proteomics, metabolomics, etc.). In this training, you will learn how to:
1. Generate activity heatmaps and expression charts comparing different pathways and regulatory networks across different species
2. Use Activity Plot, Pattern Search and Analysis Match to compare your own data against thousands of public data pre-curated and pre-analyzed representing an array of disease states, conditions and other biological conditions
3. Create expression and correlation plots using pre-curated and pre-analyzed public data to validate and confirm findings derived from a comparison analysis

Related videos

Discovery and Research

Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...

419 views May 18, 2020

Multi-omics experiments allow researchers to make important discoveries in...

Discovery and Research

Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune...

515 views May 08, 2020

Zoonotic coronaviruses (CoVs) are significant threats to global health, as...


Network construction and customization with QIAGEN Ingenuity Pathway Analysis

40 views May 10, 2024

This in-depth training focuses on effectively constructing a network, with or...


IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)

63 views May 02, 2024

In this 90-minute training session, you will learn how to identify target...